Torrent Pharmaceuticals rose 1.74% to Rs 1,356.80 at 15:24 IST on BSE after consolidated net profit surged 174.6% to Rs 357 crore on 29.9% rise in net sales to Rs 1473 crore in Q4 March 2016 over Q4 March 2015.
The result was announced after market hours yesterday, 23 May 2016.Meanwhile, the S&P BSE Sensex was up 90.76 points or 0.36% at 25,321.15
On BSE, so far 68,106 shares were traded in the counter as against average daily volume of 21,189 shares in the past one quarter. The stock hit a high of Rs 1,417.95 and a low of Rs 1,250.85 so far during the day. The stock had hit a record high of Rs 1,720 on 1 September 2015. The stock had hit a 52-week low of Rs 1172.20 on 1 June 2015.
The large-cap company has equity capital of Rs 84.61 crore. Face value per share is Rs 5.
Torrent Pharmaceuticals' consoldiated earnings before interest, taxation, depreciation and amortization (EBITDA) rose 96% to Rs 507 crore in Q4 March 2016 over Q4 March 2015. Torrent Pharmaceuticals said that the results for the Q3 December 2015 and Q4 March 2016 are after giving effect of scheme of amalgamation while figures for corresponding quarters are before giving effect of amalgamation. Hence, the figures for corresponding period and previous year are not comparable with figures of current period. It may be recalled that Torrent Pharmaceuticals had acquired 100% stake in formulation facility of Zyg Pharma on 17 July 2015.
Torrent Pharma is the flagship company of the Torrent Group. The company is engaged in the manufacture of formulations and bulk drugs.
Powered by Capital Market - Live News